In 2018, Masahiko Watanabe's team analyzed the surgical specimens of 51 patients with breast cancer and found that KK-LC-1 could be detected in triple-negative breast cancer cases and all tumors without estrogen receptor expression, and its expression level in tumor tissues was significantly higher than that in paracancerous tissues. This evidence concerns the gene CT83 and neoplasm.